JOHN J MURPHY
Veterinary in Cambridge, MA
License number
Massachusetts 688
Issued Date
Jul 15, 1931
Expiration Date
Feb 28, 1986
Type
Veterinarian
Address
Address
Cambridge, MA 02140
Professional information
Director, Industry Marketing At Akamai Technologies
Position:
Director, Industry Marketing at Akamai Technologies
Location:
Greater Boston Area
Industry:
Computer Software
Work:
Akamai Technologies
- Cambridge, MA since 2012
-
Director, Industry Marketing
Infor Global Solutions
Feb 2008 - Feb 2012
-
Global Director, Product Marketing and Product Management
Impress Software
Dec 2005 - Feb 2008
-
Director, Product Marketing
MRO Software (Acquired by IBM)
Oct 2001 - Oct 2005
-
Dir, Enterprise Sales Support, Marketing & Operations
Bowstreet
May 2000 - Aug 2001
-
Product Marketing Manager (Acquired by IBM)
HP (E-Services and OpenView)
Aug 1997 - May 2000
-
Product Marketing / Product Management
Comac
Dec 1988 - Jul 1995
-
Director, Customer Service and R&D
Education:
University of Pennsylvania - The Wharton School 1995 - 1997
MBA, Marketing, Finance Northeastern University 1982 - 1987
BS, Computer Science
MBA, Marketing, Finance Northeastern University 1982 - 1987
BS, Computer Science
President, Global Workplace Solutions At Johnson Controls, Inc
Position:
President, Global Workplace Solutions at Johnson Controls
Location:
Greater Milwaukee Area
Industry:
Facilities Services
Work:
Johnson Controls
- Greater Milwaukee Area since Jun 2013
-
President, Global Workplace Solutions
Johnson Controls, Inc.
- Greater Milwaukee Area Oct 2009 - Jun 2013
-
VP/GM, North America-Systems, Latin America, Middle East, and Global Security
Johnson Controls, Inc.
- Brussels Area, Belgium 2007 - Nov 2009
-
VP/MD, Europe and Africa
Beloit Corporation
- Deerfield, IL 1996 - 1999
-
Senior Vice President
Monitor Company
- Cambridge, MA 1993 - 1996
-
Consultant
US Army
1985 - 1992
-
Captain/Company Commander
Education:
Harvard Business School 1992 - 1994
MBA, General Management Northwestern University 1985 - 1987
MS, Chemical Engineering University of Notre Dame 1981 - 1985
BS, Chemical Engineering
MBA, General Management Northwestern University 1985 - 1987
MS, Chemical Engineering University of Notre Dame 1981 - 1985
BS, Chemical Engineering
Languages:
French
Help Desk Engineer At Millennium Pharmaceuticals
Position:
Help Desk Engineer at Millennium Pharmaceuticals
Location:
Greater Boston Area
Industry:
Information Technology and Services
Work:
Millennium Pharmaceuticals
- Cambridge, MA 02139 since Jan 2013
-
Help Desk Engineer
All IT Supported.com / GeeksMobileUSA.com
- Charlestown, MA 02129 Jun 2012 - Feb 2013
-
Remote Support Engineer -Business/Help Desk Support
Dell
Jun 2011 - Dec 2012
-
Field Service Representative
Accounting Manger At Lux Research
Position:
Accounting Manager at Lux Research
Location:
Boston, Massachusetts
Industry:
Management Consulting
Work:
Lux Research
- Greater Boston Area since Feb 2012
-
Accounting Manager
Mercatus LLC
- Boston, MA Sep 2009 - Jan 2012
-
Finance Manager
Boston Consulting Group
- Greater Boston Area Jun 2005 - Sep 2009
-
Lead Accountant - Compensation and Partnership Accounting
Thomson Financial
- Greater Boston Area Apr 2003 - May 2005
-
Senior Accountant
Arthur D. Little
- Cambridge, MA Nov 2001 - Apr 2003
-
Treasury Operations Manager
Arthur D. Little
- Cambridge, MA Jun 1999 - Dec 2000
-
Snr. Accountant
Gordon Brothers Group
- Greater Boston Area Aug 1997 - Jun 1999
-
Staff Accountant
Education:
Dublin Business School 1989 - 1993
Skills:
Financial Analysis, Financial Reporting, Corporate Finance, Internal Controls, Accounting, Financial Modeling, Forecasting
Method Of Making Genetically Stable Mutants Of Vibrio Cholerae
US Patent:
4264737, Apr 28, 1981
Filed:
Jul 20, 1979
Appl. No.:
6/059293
Inventors:
John R. Murphy - Cambridge MA
Assignee:
President and Fellows of Harvard College - Cambridge MA
International Classification:
C12N 1500, C12N 136, C12R 163
US Classification:
435172
Abstract:
Incubation of a parent strain of Vibrio cholerae at elevated temperature to produce a hypotoxinogenic variant strain and mutation of the variant strain results in mutant strains which retain the biotype and antigens of the parent strain, and which are genetically stable and useful as live oral vaccines for immunization against cholera. Preferably, a hypotoxinogenic mutant which is also non-pathogenic in animal model systems is isolated by the method disclosed in this application.